ASTH
Astrana Health Inc
34.40$
+0.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 88.9% | 69.3% | 72.3% | 29.4% | 33.7% | 45.2% | 41.4% | 46.6% | 44.3% | 49.4% | 47.1% | 38.9% | |
| 72.0% | 47.4% | 42.0% | 24.4% | 20.8% | 14.2% | 23.7% | 26.9% | 29.8% | 31.5% | 21.3% | 19.4% | |
| 72.0% | 47.4% | 42.0% | 24.6% | 21.1% | 30.2% | 31.9% | 33.0% | 30.4% | 31.7% | 21.5% | 19.4% | |
| 16.2% | 20.4% | 29.0% | 4.1% | 11.2% | 13.6% | 7.4% | 11.4% | 12.4% | 15.8% | 24.0% | 18.4% | |
| 0.0% | 1.4% | 0.0% | 0.0% | – | – | – | -7.7% | – | – | – | – | |
| 6.1% | 6.4% | 5.8% | 2.8% | 2.5% | 3.6% | 5.9% | 7.9% | 13.3% | – | – | – | |
| 5.2% | 8.3% | 7.9% | 38.7% | 36.2% | 32.7% | 29.2% | 28.4% | 27.8% | 29.9% | 30.9% | 38.9% | |
| 0.6% | 7.0% | 9.2% | 21.1% | 16.9% | 14.1% | 10.6% | 9.5% | 8.0% | 7.7% | 8.7% | 12.2% | |
| 117.1% | 56.3% | 98.7% | 31.5% | 20.7% | 50.5% | 45.5% | 41.1% | 42.2% | 56.0% | 62.1% | 74.8% | |
| 25.8% | 38.0% | 70.4% | 22.3% | 14.0% | 14.5% | 14.1% | 13.2% | 15.4% | 23.4% | 27.0% | 27.7% | |
| 4.7% | 1.0% | 23.7% | 1.1% | 0.0% | 1.7% | 1.7% | 0.4% | 0.5% | 2.7% | 1.1% | 2.5% | |
| 8.7% | 10.4% | 17.3% | 5.5% | 0.9% | 0.9% | 1.2% | 0.6% | 1.1% | 1.0% | 1.1% | 2.0% | |
| 81.1% | 7.3% | 24.2% | 0.1% | 2.5% | 31.9% | 28.2% | 21.1% | 21.1% | 27.7% | 31.4% | 44.7% | |
| -17.1% | 29.7% | 1.3% | 32.6% | 35.2% | 26.3% | 40.5% | 51.7% | 56.2% | 65.8% | 52.6% | 35.1% | |
| -172.4% | -146.6% | -182.4% | 0.4% | 3.5% | 4.4% | 8.5% | 15.8% | 18.9% | 26.0% | 21.1% | 13.9% | |
| 51.3% | 26.6% | 29.2% | 5.8% | 7.4% | 5.0% | 4.6% | 5.2% | 4.7% | 5.0% | 3.6% | 2.2% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.